Matsuda Kenji, Hotta Tsukasa, Takifuji Katsunari, Kobayashi Yasuhito, Tsuji Takeshi, Nagai Yugo, Horiuchi Tetsuya, Yamaue Hiroki
Second Department of Surgery, Wakayama Medical University, School of Medicine,Wakayama, Japan
Am Surg. 2011 May;77(5):602-7.
The purpose of this study was to clarify the prognostic factors in patients with peritoneal carcinomatosis from colorectal origin, especially focusing on lymph node status. Between 1998 and 2007, 126 patients who underwent surgical treatment for primary colorectal cancer with peritoneal carcinomatosis were retrospectively assessed concerning prognostic factors. To estimate survival, we formulated a scoring system by numbers of independent poor prognostic factors. According to a multivariate analysis, extent of peritoneal carcinomatosis (hazard ratio, 1.93; 95% confidence interval, 1.19-3.13; P = 0.008) and lymph node ratio (hazard ratio, 1.87; 95% confidence interval, 1.05-3.33; P = 0.034) were found to be independent poor prognostic factors for survival. Furthermore, we demonstrated that score formulated by the number of these criteria was highly predictive of survival (P < 0.001). The 5-year survival rate for patients with score 0 (having no criteria), score 1 (having one criterion), and score 2 (having two criteria) were 25.1 per cent, 6.2 per cent, and 0 per cent, respectively. Lymph node ratio is an important prognostic factor in addition to the extent of peritoneal carcinomatosis after resection of primary colorectal carcinoma. Patients without these criteria have a favorable outcome, and therefore should be considered for further aggressive surgery and intraperitoneal chemotherapy.
本研究的目的是阐明结直肠来源的腹膜癌患者的预后因素,尤其关注淋巴结状态。1998年至2007年间,对126例因原发性结直肠癌伴腹膜癌而接受手术治疗的患者的预后因素进行了回顾性评估。为了评估生存情况,我们根据独立的不良预后因素数量制定了一个评分系统。多因素分析显示,腹膜癌范围(风险比,1.93;95%置信区间,1.19 - 3.13;P = 0.008)和淋巴结比率(风险比,1.87;95%置信区间,1.05 - 3.33;P = 0.034)是生存的独立不良预后因素。此外,我们证明根据这些标准数量制定的评分对生存具有高度预测性(P < 0.001)。评分为0(无标准)、1(有一项标准)和2(有两项标准)的患者的5年生存率分别为25.1%、6.2%和0%。除原发性结直肠癌切除术后的腹膜癌范围外,淋巴结比率也是一个重要的预后因素。没有这些标准的患者预后良好,因此应考虑进一步积极手术和腹腔内化疗。